OATech+ Network: Using Technology to work towards improving Patient Outcomes Leanne Sawle.

Slides:



Advertisements
Similar presentations
Mental health strategy of the Medical Research Council (UK) Opportunities for European engagement and a role of FEAM European Parliament 22 nd March 2011.
Advertisements

THE CARERS RESEARCH PARTNERSHIP Elizabeth McDade.
UK-Brazil urban research network Oxford Workshop 9-11 March 2011 UK-Brazil Urban Research Network.
1 Stakeholder Engagement in Relu Jeremy Phillipson Assistant Director, Relu Programme.
Patients Matter: Engaging Patients as Collaborators to Improve Osteoarthritis (OA) Care in Alberta Alberta Health Services.
A New Vision for Chronic Osteoarthritis Management A Call to Action from the Chronic Osteoarthritis Management Initiative (COAMI)
A New Vision for Chronic Osteoarthritis Management A Call to Action from the Chronic Osteoarthritis Management Initiative (COAMI) Prepared by the United.
Measuring the Burden of Musculoskeletal Disease Musculoskeletal Conditions and Injuries: Status and Goals United States Bone and Joint Decade.
Meredith Newlin, Research Fellow and PhD Candidate Centre for Mental Health Social Research This presentation presents independent research funded by the.
Seventh framework programme CAPACITIES specific programme Activities of international cooperation Coordination Support Action - Grant agreement no.:
Experience of a Knowledge and Resource Exchange Event Dr Alison Porter-Armstrong Health & Rehabilitation Sciences Research Institute.
Keynote address: Musculoskeletal conditions as a challenge for policy making Professor Paul Emery President of EULAR Professor of Rheumatology, University.
CADTH Therapeutic Reviews
The burden of RMDs on patients and their families The value of early intervention, prevention and better management of RMDs Marios Kouloumas Chairperson.
INTERACTIVE QUESTIONS. Discussion Question What is chronic joint pain? Pathophysiology.
Health Stakeholder Consultation Event Frances Spillane, Assistant Secretary General Department of Health 11 March 2015.
Intervention with the Elderly Chapter 8. Background The elderly population is growing in industrialized countries. This is due to: – Improved medical.
Disease Management: High Risk Groups Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
Results from 2014 NHSRU-KTEP Environmental Scan Prepared for Policy to Practice – Investing in Your Workforce September 15, 2014 Prepared by the Nursing.
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
Agenda Setting Input and Status Agenda Setting Input and Status.
European Society of Cardiology Cardiovascular diseases in women.
Alzheimer’s Society, UK Our research programme
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Planned Commission Communication on the role of the Private Sector in Development A contribution to the reflexion on How to Innovate International Cooperation.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
Challenges and healthy ageing: the role of resilience across the life course 1 st Meeting of ResNet 19 th May, 2009 Bangor University.
D4FF55A0-6B6F BF422A9BA9 Present by: Xiao Chen On December 7, 2015.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
NoWCADD Progress Report 2015
Musculoskeletal Pain Clinical Study Group Report on Podiatry Consensus Meeting Prof. Jim Woodburn School of Health & Social Care. Glasgow Caledonian University,
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
‘Enhancing musculoskeletal research in primary care: engaging a community musculoskeletal physiotherapy service in research studies’ Presented by : Carol.
The Role of the Work and Health Unit and Engagement All Party Group on Health & Work 25 May 2016 Deborah Jamieson, OBE Work and Health Unit.
1 Study on the Coverage of Chronic Diseases in Social and Health Protection Systems: A Comparative Analysis of Trends in Developed Countries and in the.
2016 Implementing the Recovery Package. 1. Overview of Living with and Beyond Cancer 2.Promote wider understanding of Recovery Package 3.Explore stratification.
Transforming Population Health in Greater Manchester – New Economy Breakfast Seminar – 13 July 2016.
Presented by: Alice Willett, UK Presented to: FAO; 18 October 2016, Rome, Italy Animal Health and Greenhouse Gas Emissions Intensity Network.
Proctor’s Implementation Outcomes
EULAR Study Group on Osteoarthritis
Stephen Joseph Galli, MD  Journal of Allergy and Clinical Immunology 
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Musculoskeletal Health in Europe
Champlain LHIN Collaboration
Action: BM0806 Recent Advances in Histamine Receptor H4R Research
Towards UK poSt Arthroplasty Follow-up rEcommendations: UK SAFE
Call topic identification for 2019 call
EXPLORING GLOBAL COOPERATION OPPORTUNITIES
An Industry Perspective Nicole Denjoy COCIR Secretary General
Funding opportunities in illicit drugs research in H2020
Sam Kynman – Executive Director, European Pain Federation EFIC
Improving Care for Older People in Acute Care
EULAR Study Group on Osteoarthritis
Global and local: Science for policy and the role of networks
Nuzhat Ali, National Lead MSK Health
The MSK-HQ Developing a generic Musculoskeletal Patient Reported Outcome Measure Policy & Public Affairs Team, Arthritis Research UK e.
Experimental Medicine Challenge Grants Round 3
Supporting the Knowledge into Action Review May 2011
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
OATech+ Network: Funding Review
Figure 2 Phenotypes of osteoarthritis
BioCapital Europe 2019, Amsterdam
EULAR Study Group on Osteoarthritis
OATech+ Network: A Multidisciplinary, Technology-Driven Approach Towards Improving Patient Outcomes Leanne Sawle.
OATech+ Network: Funding Review
Presentation transcript:

OATech+ Network: Using Technology to work towards improving Patient Outcomes Leanne Sawle

Overview Osteoarthritis (OA) affects 8.75 million people in the UK (Mobasheri & Batt 2016) Places a considerable burden upon the economy (Woolf et al. 2012)  Seriously impairs the quality of life of those affected (Hiligsmann et al. 2013) Despite this current diagnostic and treatment strategies could be improved (Bhatia, 2013)

Improving patient outcomes OATech + Network (2016-2020): Optimising Treatment Identify and address technology-based knowledge gaps in the field of osteoarthritis Multidisciplinary approach Improving patient outcomes

Network Priorities (Research Forum, 2018) Imaging Current technology? What does new technology bring? Creation of a shared OA data resource / repository Data harmonisation / recommendations Technology and pain

Role of technology in stratification Terminology Joint diseases? OA? Post traumatic? Role of technology in OA outcomes measurement Role of technology in facilitating concordance Technology as intervention

Activity Proposals and Funding Multidisciplinary involvement Technology link Outputs must contribute to the network development

Proposals Creation of an OA data sets resource (combining large data sets) Exploring stratification from a multidisciplinary perspective: Focus meeting / Delphi study (novel, experimental technology) Imaging data Clinical working group risk stratification tool

Creating imaging standards (consensus paper and working group) Development of an OATech+ roadmap for identifying high level evidence and routes to impact translation Healthy lifestyle interventions and the role of technology. Review to understand the situation and seed funding applications for technology interventions

Public engagement events in biomechanics and mechanobiology Modelathon and sandpit (multi-scale modelling of OA; explore relationship between biomechanics and pain) Mentorship programme and opportunities to upskill in multidisciplinary fields

Other Activities Stakeholder engagement Events Funding application

Timeline Award of this years funding of activities Joint public engagement event Refinement of activity funding plan for next year

www.oatechnetwork.org twitter.com/OATechNetwork www.facebook.com/OATechNetwork/

References Bhatia, D., Bejarano, T. and Novo, M. (2013) ‘Current interventions in the management of knee osteoarthritis’, Journal of Pharmacy and BioAllied Sciences, 5(1), pp. 30–38. doi: 10.4103/0975-7406.106561. Hiligsmann, M. et al. (2013) ‘Health economics in the field of osteoarthritis: an expert’s consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).’, Seminars in Arthritis and Rheumatism, 43(3), pp. 303–313. Mobasheri, A. and Batt, M. (2016) ‘An update on the pathophysiology of osteoarthritis.’, Annals of Physical and Rehabilitation Medicine, 59, pp. 333–339. Woolf, A. D., Erwin, J. and March, L. (2012) ‘The need to address the burden of musculoskeletal conditions.’, Best Practice & Research Clinical Rheumatology, 26(2), pp. 183–224.